Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
Sales of Olainfarm in Nine Months Reached 78.7 Million Euros
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids Finanšu pārskati
Valoda EN
Statuss Publicēts
Versija
Datums 2016-11-30 18:42:58
Versijas komentārs
Teksts

  

Olaine, November 30, 2016

 

Sales of Olainfarm in Nine Months Reached 78.7 Million Euros

 

Unaudited income statement of AS Olainfarm for nine months of 2016 shows that with sales of 78.7 million euros, the group has experienced its best nine months in terms of sales.  Sales have increased by 9% compares to the same period of 2015.  Profit of  AS Olainfarm during this period was 7.8 million euros, whish represents a reduction by 36% compared to 2015.  Major sales markets during this period were Russia, Latvia, Ukraine and Belarus

 

This third quarter was also the best third quarter in corporate history, as the sales reached 25.2 million euros, whish represents an increase by 15% compared to the third quarter of 2015.  The net profit of the third quarter was 1.66 million euros, which is by 41% less than during the third quarter of 2015.  The profit was adversely influenced by provisions of 2.2 million euros for Ukrainian and Russian receivables and for potential value impairment of investments in Belarussian company NPK Biotest.

 

„Success of Olainfarm in the near future will to a large extent depend on how well will we diversify our sales markets and products and how good we will be at maintaining our existing positions.  Therefore we continue with registration of products in existing and new markets and acquire pharma related companies, which help us expand our exports geographically. Within the next two years we will have to integrate acquired companies into our group, in order to use all opportunities provided by joint administrative, marketing and logistics structure,” says Salvis Lapins, Member of Olainfarm’s Board.

 

 

During the first nine months of 2016, sales to most of Company’s key markets continued growing, except Russia, where they fell by 7% compared to nine months of 2015, and The Netherlands, when they fell by as much as 67% during the same period. It should be noted, however, that partially shipments previously made to WHO in The Netherlands this year were shipped directly to Ukraine, thus increasing Ukrainian sales. The biggest sales increases were achieved in Uzbekistan (+72%), Turkmenistan and Ukraine (+38% each) and the UK (+24%).  In total in nine months, products of AS Olainfarm were sold to 39 countries in four continents.

 

 

During the nine months  period, registration processes continued in Turkey, Armenia, Russia, Kazakhstan, Lithuania, Moldova, Bosnia and Herzegovina, Myanmar, Cameroon and Vietnam. Registration of several products has been successfully completed in Estonia, Kyrgyzstan, Azerbaijan, Turkmenistan, Bosnia and Herzegovina. During the third quarter registration of tree food supplements have been completed in Lithuania.

 

Annual meeting of shareholders of A/s “Olainfarm” convened on June 7, 2016 approved operating plan of the Group for 2016.  According to it, sales of the Group in 2016 are planned to be 100 million euros, but the net profit will reach 10 million euros.  According to unaudited report for 9 months of 2016, during this period 79% of annual sales target and 78% of annual profit target is met.

 

 

 

 

 

 

Condensed Consolidated Statement of  Financial Position

Group

   

30.09.2016

31.12.2015

   

EUR '000

EUR '000

 

     ASSETS

   

NON-CURRENT ASSETS

   

Intangible assets

          28 390

          20 591

Property, plant and equipment

          38 897

          35 579

Financial assets

            7 122

            4 917

 

TOTAL NON-CURRENT ASSETS

          74 409

          61 087

CURRENT ASSETS

   

Inventories

          22 989

          20 990

Receivables

          32 441

          30 480

Cash

            7 794

            5 574

 

TOTAL CURRENT ASSETS

          63 224

          57 044

TOTAL ASSETS

        137 633

        118 131

     
 

           EQUITY AND LIABILITIES

   

EQUITY

   

Share capital

          19 719

          19 719

Share premium

            2 504

            2 504

Reserves

               322

               322

Retained earnings

          70 988

          65 773

Non-controlling interests

                 39

                 30

 

TOTAL EQUITY

          93 572

          88 348

LIABILITIES

   

Non-current liabilities

   

Borrowings

          18 201

            8 560

Deferred corporate income tax

            2 303

            1 947

Deferred income

            2 927

            2 656

 

Total Non-Current Liabilities

          23 431

          13 163

Current liabilities

   

Borrowings

            7 979

            4 258

Trade payables and other liabilities

          12 176

          11 562

Deferred income

               475

               800

 

Total Current Liabilities

          20 630

          16 620

 

TOTAL LIABILITIES

          44 061

          29 783

TOTAL EQUITY AND LIABILITIES

        137 633

        118 131

 

 

 

 

 

 

Consolidated statement of comprehensive income

Group

Group

 

Q3 2016

Q3 2015

9M 2016

9M 2015

 

EUR '000

EUR '000

EUR '000

EUR '000

Net revenue

       25 158

       21 792

       78 675

       71 861

Cost of goods sold

        (9 685)

        (7 346)

      (30 005)

      (23 588)

Gross Profit

       15 473

       14 446

       48 670

Pielikumi
Olainfarm_Ill_2016_consolidated FS_ENG.pdf (1141.26 kB)